Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Virological Methods|March 26, 2021
A mid-throughput HBV replication inhibition assay capable of detecting ribonuclease H inhibitorsQilan Li, Tiffany C Edwards, Nathan L Ponzar, et al.Journal of Medicinal Chemistry|April 4, 2022
4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 EndonucleaseTianyu He, Tiffany C Edwards, Jiashu Xie, et al.Molecules (Basel, Switzerland)|March 29, 2023
Enhanced Remdesivir Analogues to Target SARS-CoV-2Ryuichi Majima, Tiffany C Edwards, Christine D Dreis, et al.Chemmedchem|July 25, 2022
8-Hydroxy-1,6-naphthyridine-7-carboxamides as Inhibitors of Human Cytomegalovirus pUL89 EndonucleaseEunkyung Jung, Ryuichi Majima, Tiffany C Edwards, et al.Antiviral Research|February 7, 2024
Identification and assessment of the 1,6-dihydroxy-pyridin-2-one moiety as privileged scaffold for HBV ribonuclease H inhibitionErofili Giannakopoulou, Vasiliki Pardali, Tiffany C Edwards, et al.Antiviral Research|February 16, 2019
Inhibition of HBV replication by N-hydroxyisoquinolinedione and N-hydroxypyridinedione ribonuclease H inhibitorsTiffany C Edwards, Nagraj Mani, Bruce Dorsey, et al.European Journal of Medicinal Chemistry|June 20, 2021
Metal binding 6-arylthio-3-hydroxypyrimidine-2,4-diones inhibited human cytomegalovirus by targeting the pUL89 endonuclease of the terminase complexLei Wang, Tiffany C Edwards, Rajkumar Lalji Sahani, et al.Bioorganic Chemistry|October 20, 2022
Repurposing N-hydroxy thienopyrimidine-2,4-diones (HtPD) as inhibitors of human cytomegalovirus pUL89 endonuclease: Synthesis and biological characterizationTianyu He, Tiffany C Edwards, Ryuichi Majima, et al.Acta Pharmaceutica Sinica. B|July 18, 2022
Discovery of <i>N</i>-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV)Sameera Senaweera, Tiffany C Edwards, Jayakanth Kankanala, et al.Pharmaceuticals (Basel, Switzerland)|January 25, 2025
p97 Inhibitors Possessing Antiviral Activity Against SARS-CoV-2 and Low CytotoxicityRui Ding, Tiffany C Edwards, Prithwish Goswami, et al.Pageof 2